Abstract:Invading pathogen nucleic acids are recognized and bound by cytoplasmic (retinoic acid-inducible gene I [RIG-I]like) and membrane-bound (Toll-like) pattern recognition receptors to activate innate immune signaling. Modified nucleotides, when present in RNA molecules, diminish the magnitude of these signaling responses. However, mechanisms explaining the blunted signaling have not been elucidated. In this study, we used several independent biological assays, including inhibition of virus replication, RIG-I: RNA binding assays, and limited trypsin digestion of RIG-I: RNA complexes, to begin to understand how RNAs containing modified nucleotides avoid or suppress innate immune signaling. The experiments were based on a model innate immune activating RNA molecule, the polyU/UC RNA domain of hepatitis C virus, which was transcribed in vitro with canonical nucleotides or with one of eight modified nucleotides. The approach revealed signature assay responses associated with individual modified nucleotides or classes of modified nucleotides. For example, while both N-6-methyladenosine (m6A) and pseudouridine nucleotides correlate with diminished signaling, RNA containing m6A modifications bound RIG-I poorly, while RNA containing pseudouridine bound RIG-I with high affinity but failed to trigger the canonical RIG-I conformational changes associated with robust signaling. These data advance understanding of RNA-mediated innate immune signaling, with additional relevance for applying nucleotide modifications to RNA therapeutics.IMPORTANCE The innate immune system provides the first response to virus infections and must distinguish between host and pathogen nucleic acids to mount a protective immune response without activating autoimmune responses. While the presence of nucleotide modifications in RNA is known to correlate with diminished innate immune signaling, the underlying mechanisms have not been explored. The data reported here are important for defining mechanistic details to explain signaling suppression by RNAs containing modified nucleotides. The results suggest that RNAs containing modified nucleotides interrupt signaling at early steps of the RIG-I-like innate immune activation pathway and also that nucleotide modifications with similar chemical structures can be organized into classes that suppress or evade innate immune signaling steps. These data contribute to defining the molecular basis for innate immune signaling suppression by RNAs containing modified nucleotides. The results have important implications for designing therapeutic RNAs that evade innate immune detection.

Base-modified nucleotides mediate immune signaling in bacteria

Bacterial origins of cyclic nucleotide-activated antiviral immune signaling

Functionally comparable but evolutionarily distinct nucleotide-targeting effectors help identify conserved paradigms across diverse immune systems

Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

Direct activation of a bacterial innate immune system by a viral capsid protein

Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways

Phages reconstitute NAD to counter bacterial immunity

Pharmacological potential of cyclic nucleotide signaling in immunity

Phages reconstitute NAD + to counter bacterial immunity

Cyclic CMP and cyclic UMP mediate bacterial immunity against phages

The arms race between bacteria CBASS and bacteriophages

A conserved signaling pathway activates bacterial CBASS immune signaling in response to DNA damage

A conserved family of immune effectors cleaves cellular ATP upon viral infection

Recent advances and perspectives in nucleotide second messenger signaling in bacteria

Bacterial cGAS senses a viral RNA to initiate immunity

Bacteriophage antidefense genes that neutralize TIR and STING immune responses

Bacterial NLR-related proteins protect against phage

Insights into the modulation of bacterial NADase activity by phage proteins

Post-translational modification control of viral DNA sensors and innate immune signaling

Cyclic GMP–AMP signalling protects bacteria against viral infection

RNAs Containing Modified Nucleotides Fail to Trigger RIG-I Conformational Changes for Innate Immune Signaling